Altasciences, a fully integrated drug development solution company, and VoxCell BioInnovation (“VoxCell”), a leader in 3D bioprinting and human-like tissue modeling, are pleased to announce a ...
AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...
CAMBRIDGE, United Kingdom--(BUSINESS WIRE)--CN Bio, a leading provider of Organ-on-a-chip (OOC) Systems and solutions that accelerate drug discovery and development workflows, today announced the ...
Preclinical toxicology studies face a significant challenge: animal models cannot self-report side effects. This limitation proves particularly problematic when evaluating treatments for which subtle ...
From biomarker discovery to safety pharmacology, CD BioSciences preclinical development services for anti-aging drug research span the full range. These services, by combining advanced technology and ...
Current timeline for drug development is 10-12 years and costs approximately $1-3 billion. Tevogen’s approach has the potential to shorten timelines and substantially reduce costs. Tevogen’s AI ...
AI is transforming drug discovery, but accurately predicting patient responses remains challenging. Considering the ongoing need to connect drugs with the right patients and rising drug costs, ...
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 9th Annual Drug Discovery & Development Virtual Event on February ...
Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback